The new vaccine is a combination of GSK’s already-approved vaccines Bexsero and Menveo and is designed to protect against meningitis and blood poisoning caused by the A, B, C, W, and Y ...

GSK’s five-in-one meningococcal vaccine has been recommended by the US Centers for Disease Control and Prevention’s (CDC) immunisation panel as part of the adolescent meningococcal vaccination ...

Thanks in part to research led by Bristol, the UK has played a leading role in the fight against the disease with its pioneering use of a vaccine – Bexsero – that is both effective at reducing cases ...

This second article in our series looking at some of the shortlisted candidates focuses on Novartis' meningococcal B vaccine Bexsero. Few infections will strike as much fear into a parent as ...

An immunization within the last 10 years for Tetanus/Diphtheria (Td/Tdap). If under the age of 23, a quadrivalent meningococcal conjugate vaccine (MCV4) on or after your 16th birthday. Acceptable ...

Vaccine recommended to help protect persons ... Important Safety Information for BEXSERO in the US The following is based on the US Prescribing Information for BEXSERO. Please consult the full ...

GSK announced two important endorsements from the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on ...

Scientific Conference by GlaxoSmithKline on the Launch of “Bexsero,” Egypt’s First Vaccine for the Prevention of Meningococcal Bacterial Meningitis (Group B) Sunday 13 Apr 2025 ...